Search results
Results From The WOW.Com Content Network
Many of these cases have lead to class action lawsuits and proceedings by the Federal Trade Commision (FTC), resulting in a number of settlements worth millions — or even billions — of dollars ...
Bank of America must be used to shelling out billions to settle class-action lawsuits by now. ... big-selling diabetes drug Actos. In the 2015 settlement, Takeda agreed to pay $2.4 billion while ...
The lawsuit is the latest to accuse employer-sponsored health plans of failing to negotiate lower prices for drugs on behalf of participants, as prescription drug costs continue to rise sharply in ...
The Los Angeles Times headlined "Public Faces Overdose of Similar Drug Names." [14] The market for Zantac [15] and its competitors was described in 2005 as 13.5 billion US dollars. [16] The product's problem was described by The New York Times as being "that a potential cancer-causing contaminant can build up in the drug when stored for long ...
The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [2]
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
Kaplan, Inc.#Class-action lawsuit; Keele Valley Landfill#Resident class action lawsuit; Kemper Corporation#Class-action lawsuit; Kids for cash scandal#Victim lawsuits; Kweku Hanson#Class action lawsuit against Ocwen Federal FSB; Lead contamination in Washington, D.C. drinking water#Class-action lawsuit; Long-term effects of benzodiazepines# ...
Aug 17 (Reuters) - The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants.